Guardant Health (GH) Price Forecast: Breakout Opens Path Toward $250

Published: October 06, 2026

Key Points

• Long-term breakout gains momentum.
• Record high confirms bullish strength.
• Multiple timeframes align bullishly.
• Fibonacci targets reach $217.17.
• Measured target points toward $249.74.

Long-Term Breakout Gains Momentum

Guardant Health, Inc. (GH), a precision oncology company, has recently extended its breakout from a long-term basing pattern, indicating the potential for a new upward movement. The stock reached a new record high of $187.38, following a significant breakout above the previous high of $181.07 established in 2021. This breakout was triggered in mid-September, and since then, GH has consolidated within a tight range near its highs, following a bullish ascending triangle formation.

Bullish Patterns Align Across Timeframes

The alignment of bullish patterns across both long-term and short-term timeframes suggests a strong potential for upward movement. The synchronization of these patterns may enhance the bullish follow-through if buyers maintain control of the stock.

Fibonacci Targets Map Further Upside

Key support has been established at a higher weekly low of $176.37. The breakout was confirmed with a daily close above $183.50, marking a new record daily closing price at $187.22. Fibonacci extensions indicate potential upside targets at $195.88, $213.12, and $217.17, while the measured target from the ascending triangle pattern suggests a possible price near $235.88.

Moving-Average Test Confirms Buyer Strength

Technically, GH is positioned strongly due to the bullish pattern alignment across multiple timeframes. If buyers can maintain control above the key support level, the upside follow-through is likely to align with the long-term bullish trend. A recent pullback tested the 20-day moving average, which was followed by a rejection at this level, indicating typical bullish behavior.

Shortening Consolidations Point Toward $250

The transition from a larger ascending triangle to a smaller bullish flag indicates improving momentum among buyers. The consolidation period is shortening, reflecting more aggressive buying behavior. A conservative estimate of a measured move suggests a target of approximately $249.74, based on the previous advance of at least 75.8% that preceded the ascending triangle formation. This target, along with Fibonacci levels, indicates further upside potential if GH can sustain its breakout. The immediate challenge remains for buyers to defend the $176.37 level and maintain the stock above its breakout structure.

About the Author

Bruce Powers is a Senior Analyst with over 20 years of experience in financial markets. He holds an MBA and is a CMT® charter holder. Bruce has served as head of trading strategy at hedge funds and as a corporate advisor for trading firms, providing actionable insights through technical and fundamental analyses.